PPARG is involved and acts downstream from the secondary KEGG asthma disease pathway PI3K-Akt signaling pathway through the AMP-activated protein kinase (AMPK) signaling pathway, to inhibit cell growth, cell survival and protein synthesis (KEGG). The gene discussed is AKT1; the disease is asthma.